Duncan Jason
Insider CIK 1741553 · ALBO General Counsel · NMRA See Remarks
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2026-08-20 | 2026-08-21 | 375,000 | — | $0 | 375,000 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2026-08-20 | 2026-08-21 | 375,000 | — | $0 | 375,000 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2026-01-08 | 2026-01-09 | 750,000 | — | $0 | 750,000 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-05-28 | 2025-05-30 | 400,000 | — | $0 | 400,000 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-05-28 | 2025-05-30 | 400,000 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-05-28 | 2025-05-30 | 500,000 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-05-28 | 2025-05-30 | 500,000 | — | $0 | 500,000 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-02-13 | 2025-02-18 | 500,000 | — | $0 | 500,000 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-02-13 | 2025-02-18 | 400,000 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-02-13 | 2025-02-18 | 400,000 | — | $0 | 400,000 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2023-12-11 | 2023-12-12 | 400,000 | — | $0 | 400,000 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | D To issuer deriv | 2023-03-02 | 2023-03-02 | 37,500 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | D To issuer deriv | 2023-03-02 | 2023-03-02 | 15,900 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | D To issuer deriv | 2023-03-02 | 2023-03-02 | 65,850 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | D To issuer deriv | 2023-03-02 | 2023-03-02 | 23,700 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | D To issuer deriv | 2023-03-02 | 2023-03-02 | 24,337 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | D To issuer deriv | 2023-03-02 | 2023-03-02 | 10,063 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | U Tender | 2023-03-02 | 2023-03-02 | 3,296 | — | $0 | 0 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2023-01-23 | 2023-01-23 | 228 | $43.80 | $10.0K | 14,146 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2023-01-19 | 2023-01-20 | 938 | $43.90 | $41.2K | 14,374 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award | 2023-01-19 | 2023-01-25 | 55,000 | — | $0 | 69,146 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award | 2023-01-19 | 2023-01-27 | 55,000 | — | $0 | 69,146 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-10-24 | 2022-10-25 | 456 | $19.40 | $8.8K | 14,931 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-10-24 | 2022-10-25 | 96 | $19.54 | $1.9K | 15,387 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-10-24 | 2022-10-25 | 104 | $19.58 | $2.0K | 15,483 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-07-25 | 2022-07-25 | 93 | $24.40 | $2.3K | 15,807 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-07-25 | 2022-07-25 | 220 | $23.66 | $5.2K | 15,587 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-07-22 | 2022-07-25 | 238 | $24.45 | $5.8K | 15,900 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-07-22 | 2022-07-25 | 106 | $24.68 | $2.6K | 16,138 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-04-25 | 2022-04-25 | 221 | $33.44 | $7.4K | 16,099 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-04-25 | 2022-04-25 | 91 | $33.40 | $3.0K | 16,008 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-04-22 | 2022-04-25 | 103 | $32.93 | $3.4K | 16,320 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-04-22 | 2022-04-25 | 240 | $33.07 | $7.9K | 16,423 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-01-24 | 2022-01-25 | 416 | $24.88 | $10.4K | 17,935 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-01-24 | 2022-01-25 | 96 | $25.09 | $2.4K | 17,839 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2022-01-24 | 2022-01-25 | 1,176 | $24.94 | $29.3K | 16,663 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2022-01-18 | 2022-01-20 | 15,900 | — | $0 | 15,900 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award | 2022-01-18 | 2022-01-20 | 10,800 | — | $0 | 18,351 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2021-10-25 | 2021-10-25 | 217 | $29.21 | $6.3K | 7,355 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2021-10-22 | 2021-10-25 | 95 | $28.85 | $2.7K | 7,572 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2021-07-23 | 2021-07-26 | 223 | $31.43 | $7.0K | 7,667 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2021-07-22 | 2021-07-26 | 90 | $34.13 | $3.1K | 7,890 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | M Exercise deriv | 2021-06-25 | 2021-06-28 | 6,300 | — | $0 | 24,337 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | M Exercise | 2021-06-25 | 2021-06-28 | 6,300 | $24.67 | $155.4K | 14,280 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2021-06-25 | 2021-06-28 | 6,300 | $36.22 | $228.2K | 7,980 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | M Exercise deriv | 2021-06-24 | 2021-06-28 | 9,137 | — | $0 | 10,063 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | M Exercise deriv | 2021-06-24 | 2021-06-28 | 863 | — | $0 | 30,637 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2021-06-24 | 2021-06-28 | 10,000 | $36.38 | $363.8K | 7,980 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | M Exercise | 2021-06-24 | 2021-06-28 | 9,137 | $24.04 | $219.7K | 17,117 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | M Exercise | 2021-06-24 | 2021-06-28 | 863 | $24.67 | $21.3K | 17,980 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2021-04-23 | 2021-04-26 | 222 | $32.32 | $7.2K | 7,849 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2021-04-22 | 2021-04-26 | 90 | $31.75 | $2.9K | 8,071 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | M Exercise deriv | 2021-04-01 | 2021-04-02 | 300 | — | $0 | 19,200 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | M Exercise | 2021-04-01 | 2021-04-02 | 300 | $24.04 | $7.2K | 8,461 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2021-04-01 | 2021-04-02 | 300 | $36.16 | $10.8K | 8,161 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2021-03-31 | 2021-04-02 | 1,426 | $35.04 | $50.0K | 8,161 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2021-01-22 | 2021-01-25 | 110 | $34.62 | $3.8K | 9,332 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2021-01-21 | 2021-01-25 | 23,700 | — | $0 | 23,700 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award | 2021-01-21 | 2021-01-25 | 5,500 | — | $0 | 9,442 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2020-10-22 | 2020-10-23 | 89 | $34.71 | $3.1K | 3,781 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | M Exercise deriv | 2020-09-08 | 2020-09-10 | 3,500 | — | $0 | 19,500 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | M Exercise | 2020-09-08 | 2020-09-10 | 3,500 | $24.04 | $84.1K | 7,870 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2020-09-08 | 2020-09-10 | 4,000 | $45.55 | $182.2K | 3,870 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2020-07-22 | 2020-07-23 | 91 | $25.80 | $2.3K | 4,370 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2020-04-22 | 2020-04-24 | 92 | $17.68 | $1.6K | 4,461 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | S Sale | 2020-01-22 | 2020-01-23 | 447 | $23.97 | $10.7K | 4,553 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2020-01-21 | 2020-01-23 | 31,500 | — | $0 | 31,500 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2019-01-22 | 2019-01-24 | 23,000 | — | $0 | 23,000 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award | 2019-01-22 | 2019-01-24 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ALBO ALBIREO PHARMA, INC. | A Award deriv | 2018-06-08 | 2018-06-11 | 37,500 | — | $0 | 37,500 | SEC↗ |